What makes us different from other accelerators — and why it matters for your AgeTech startup.
| Feature | AgeTech-Bharat | Y Combinator | Generic Accelerator |
|---|---|---|---|
| Fabricated Smart Homes Test with Real Elderly Users |
✓
5-10 elderly residents
|
✗
Not available
|
✗
Not available
|
| Global Investor Access US + India Networks |
✓
US + India (70+)
|
✓
Mostly US
|
Local only
|
| Guaranteed Capital Not Conditional |
✓
₹10L Day 1
|
$125K-500K
|
Uncertain
|
| Healthcare Expertise Regulatory, Clinical, Markets |
✓
Specialized
|
✗
General tech
|
✗
General
|
| Structured Program Weekly Milestones |
✓
6 months
|
✓
3 months
|
Varies
|
| Mentor Quality Healthcare Focus |
✓
15+ specialists
|
✓
50+ (general)
|
5-8 (general)
|
| Free Workspace AMTZ Campus Access |
✓
Free at AMTZ
|
✗
No workspace
|
Sometimes
|
| Cost to Startup Equity Stake |
7% equity
|
7% equity
|
3-10% varies
|
| Regulatory Support CDSCO, DPDP Act, etc. |
✓
Full support
|
✗
Limited
|
✗
None
|
Unlike generic accelerators, we exclusively focus on elderly care innovation. Every mentor, every workshop, every connection is tailored to the unique challenges of building AgeTech products in India. We understand regulatory pathways, elderly user behavior, and the nuances of this market better than anyone else.
Our fabricated smart homes with 5-10 elderly residents (60+) give you something no other accelerator can: real-world validation with your actual target users. Test your product in authentic living environments, collect behavioral data, and get video testimonials before you go to market. This de-risks your product and gives investors confidence.
₹10 lakhs on Day 1, no strings attached. Plus ₹25 lakh SAFE when you raise your next round. You know exactly what you're getting from day one, allowing you to plan and build with confidence. No uncertainty, no conditional funding — just capital when you need it most.
70+ investors spanning US Silicon Valley angels, US venture capital, India's AMTZ network, and corporate partners. We give you warm introductions to both US and Indian investors who understand healthcare and AgeTech. This dual-market access is unique and valuable for startups planning to scale globally.
Navigate CDSCO medical device certifications, DPDP Act compliance, telemedicine regulations, and healthcare data privacy with expert guidance. We've helped 20+ healthtech startups through Indian regulatory pathways. This expertise saves you months of time and prevents costly mistakes.
We specialize in AgeTech. We provide real elderly test subjects. We offer guaranteed capital. We give you global investor access. We support regulatory pathways. This combination doesn't exist anywhere else.